199 related articles for article (PubMed ID: 17484228)
21. New therapy update: ALDARA (imiquimod cream, 5%).
Abramovits W; Gupta AK
Skinmed; 2004; 3(4):215. PubMed ID: 15249782
[No Abstract] [Full Text] [Related]
22. The role of imiquimod 3.75% cream in the treatment of external genital warts.
Berman B; Wolf J
Skin Therapy Lett; 2012 Apr; 17(4):5-7. PubMed ID: 22491804
[TBL] [Abstract][Full Text] [Related]
23. Imiquimod 5% cream in the treatment of anogenital warts in female patients.
Buck HW; Fortier M; Knudsen J; Paavonen J
Int J Gynaecol Obstet; 2002 Jun; 77(3):231-8. PubMed ID: 12065134
[TBL] [Abstract][Full Text] [Related]
24. Imiquimod 5% cream treatment for rapidly progressive genital condyloma in a 3-year-old girl.
Leclair E; Black A; Fleming N
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):e119-21. PubMed ID: 23158771
[TBL] [Abstract][Full Text] [Related]
25. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
26. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
[TBL] [Abstract][Full Text] [Related]
27. Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
Santorelli C; Leo CA; Baldelli F; Cavazzoni E
Sex Transm Infect; 2017 May; 93(3):229. PubMed ID: 28432207
[No Abstract] [Full Text] [Related]
28. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
29. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
30. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
Gayed SL
Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
[TBL] [Abstract][Full Text] [Related]
32. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
Cox JT
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
[TBL] [Abstract][Full Text] [Related]
33. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
Gayed SL
Int J STD AIDS; 2002 Jul; 13(7):501-3. PubMed ID: 12171672
[TBL] [Abstract][Full Text] [Related]
34. The use of topical 5% imiquimod during pregnancy: a case series.
Einarson A; Costei A; Kalra S; Rouleau M; Koren G
Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
[No Abstract] [Full Text] [Related]
35. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
36. Therapy for anogenital verrucae in preadolescent children with topical and systemic treatment.
Chamseddin BH; Agim NG; Jarin J; Wilson EE; Mir A
Pediatr Dermatol; 2019 Sep; 36(5):623-627. PubMed ID: 31197875
[TBL] [Abstract][Full Text] [Related]
37. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts.
Vilata JJ; Badia X;
Int J STD AIDS; 2003 Jan; 14(1):11-7. PubMed ID: 12590786
[TBL] [Abstract][Full Text] [Related]
39. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
